An overview of "the guideline for clinical research using human stem cells"

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A medical system is anticipated, where high-quality medical services are accessible without anxieties whenever we are ill or injured. The innovative regenerative medical products have enabled us to overcome some life threatening diseases, however, challenges still remain for others. The Ministry of Health, Labour and Welfare has implemented "The guideline for clinical research using human stem cells" and has launched on Sept 1, 2006. The major goal of the guideline is to reinforce and ensure safe on investigational new regenerative medical products. In this paper, I will give an overview of the guideline for clinical research using human stem cells, which intends to satisfy unmet medical needs in the field of regenerative medicine as well as to keep medical advances in Japan.

Original languageEnglish
Pages (from-to)843-849
Number of pages7
JournalNippon rinsho. Japanese journal of clinical medicine
Volume66
Issue number5
Publication statusPublished - 01-01-2008

Fingerprint

Stem Cells
Guidelines
Research
Regenerative Medicine
Japan
Anxiety
Health

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{4caa156fd24c49f19796c67b1191f2cd,
title = "An overview of {"}the guideline for clinical research using human stem cells{"}",
abstract = "A medical system is anticipated, where high-quality medical services are accessible without anxieties whenever we are ill or injured. The innovative regenerative medical products have enabled us to overcome some life threatening diseases, however, challenges still remain for others. The Ministry of Health, Labour and Welfare has implemented {"}The guideline for clinical research using human stem cells{"} and has launched on Sept 1, 2006. The major goal of the guideline is to reinforce and ensure safe on investigational new regenerative medical products. In this paper, I will give an overview of the guideline for clinical research using human stem cells, which intends to satisfy unmet medical needs in the field of regenerative medicine as well as to keep medical advances in Japan.",
author = "Akifumi Matsuyama",
year = "2008",
month = "1",
day = "1",
language = "English",
volume = "66",
pages = "843--849",
journal = "Nippon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "5",

}

An overview of "the guideline for clinical research using human stem cells". / Matsuyama, Akifumi.

In: Nippon rinsho. Japanese journal of clinical medicine, Vol. 66, No. 5, 01.01.2008, p. 843-849.

Research output: Contribution to journalArticle

TY - JOUR

T1 - An overview of "the guideline for clinical research using human stem cells"

AU - Matsuyama, Akifumi

PY - 2008/1/1

Y1 - 2008/1/1

N2 - A medical system is anticipated, where high-quality medical services are accessible without anxieties whenever we are ill or injured. The innovative regenerative medical products have enabled us to overcome some life threatening diseases, however, challenges still remain for others. The Ministry of Health, Labour and Welfare has implemented "The guideline for clinical research using human stem cells" and has launched on Sept 1, 2006. The major goal of the guideline is to reinforce and ensure safe on investigational new regenerative medical products. In this paper, I will give an overview of the guideline for clinical research using human stem cells, which intends to satisfy unmet medical needs in the field of regenerative medicine as well as to keep medical advances in Japan.

AB - A medical system is anticipated, where high-quality medical services are accessible without anxieties whenever we are ill or injured. The innovative regenerative medical products have enabled us to overcome some life threatening diseases, however, challenges still remain for others. The Ministry of Health, Labour and Welfare has implemented "The guideline for clinical research using human stem cells" and has launched on Sept 1, 2006. The major goal of the guideline is to reinforce and ensure safe on investigational new regenerative medical products. In this paper, I will give an overview of the guideline for clinical research using human stem cells, which intends to satisfy unmet medical needs in the field of regenerative medicine as well as to keep medical advances in Japan.

UR - http://www.scopus.com/inward/record.url?scp=45549090538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45549090538&partnerID=8YFLogxK

M3 - Article

VL - 66

SP - 843

EP - 849

JO - Nippon rinsho. Japanese journal of clinical medicine

JF - Nippon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 5

ER -